Monte Rosa Therapeutics
GLUE
#7806
Rank
NZ$0.43 B
Marketcap
$7.06
Share price
1.54%
Change (1 day)
-39.83%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2023 (TTM): -$4.21

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.59. In 2022 the company made an earnings per share (EPS) of -$4.09 an increase over its 2021 EPS that were of -$8.67.

EPS history for Monte Rosa Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.212.88%
2022-$4.09-52.81%
2021-$8.67193.97%
2020-$2.95